Government Watchdog Recommends FDA Improve Cybersecurity Reviews

11 Sep 2018
News

Ferdous Al-Faruque @Medtech_Danny danny.al-faruque@informa.com

Executive Summary

HHS OIG is recommending US FDA hold more pre-submission meetings, amend their Refuse-to-Accept checklist and update their "Smart" template for agency reviewers to improve oversight of medical device cybersecurity.

Already Registered? Sign in to continue reading.

New to Medtech Insight? Start a free trial today!

Table
View full table

Topics

United States

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Regulation Cybersecurity Approvals

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

MT123266

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

MT123266

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Government Watchdog Recommends FDA Improve Cybersecurity Reviews

News

Executive Summary

Related Content

New Safety Framework Mixes Current Efforts, New Investments At US FDA

FDA Tries To Get 'Smart' In Standardizing 510(k) Reviews

Identify and mitigate cybersecurity risks early on, US FDA tells device sponsors

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert